Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis

<div><b>Forest plots of relative risk in OR rate.</b> (a) OR rate at week 4; (b) subanalysis based on gender; (c) subanalysis based on treatment history; (d) OR rate at month 3. CI: confidence interval; M-H: Mantel-Haenszel; RR: relative risk.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 

Figure 2 | Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 